Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Global Tech ETF (IXN) vs UnitedHealth Group Inc (UNH) Price & Performance

iShares Global Tech ETFTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

iShares Global Tech ETF vs UnitedHealth Group Inc — how do they compare? iShares Global Tech ETF trades at $149.7 (market cap $10.03B), while UnitedHealth Group Inc trades at $379.61 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 33.2× iShares Global Tech ETF's market cap, and UnitedHealth Group Inc pays a 2.5% dividend while iShares Global Tech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares Global Tech ETF for 47 Days and UnitedHealth Group Inc for 97 Days on average.

IXNUNH
Market Cap
$10.03B$332.96B
Volume
286,6177,273,749
Sector
Sector/ThematicHealth
52-Week High
$152.94$436.35
52-Week Low
$95.76$259.02
Typical Hold Time
47 Days97 Days
Enterprise Value
—$374.82B
Dividend Yield
—2.5%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Global Tech ETF

IXN trades at $152.16, down 0.51% today but near its 52-week high of $151.40, reflecting strong momentum. Technical indicators show a bullish moving average signal but overbought RSI levels. Recent news highlights the ETF's 34% gain and multiple compression, with a high-teens P/E ratio and 28.5% long-term EPS growth rate, emphasizing global tech exposure beyond the U.S.

The outlook remains positive due to AI exposure and global diversification, but risks include portfolio concentration and overbought conditions. Analyst sentiment is bullish, with buy ratings citing valuation appeal, though investors should monitor tech sector volatility and competitive pressures from international firms.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $375.98, showing minor daily weakness but maintaining a bullish technical signal. The company reported strong Q2 2026 earnings, beating estimates, and reaffirmed its full-year outlook. Revenue growth remains robust, though net margins have compressed from prior years. Analyst sentiment is overwhelmingly positive, with a consensus price target of $473.89 implying significant upside.

The outlook for UNH is favorable, driven by earnings momentum and strategic initiatives like AI investment. Key risks include regulatory pressures and medical cost trends. The stock presents a compelling opportunity for investors seeking exposure to a leading healthcare company with solid fundamentals and Wall Street support.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IXN

No sentiment data available yet.

UNH
71% Buy29% Sell
Avg holding period · 97 Days

Top news

Latest headlines on both assets

About iShares Global Tech ETF

IXN provides exposure to global electronics, software, and hardware companies. It tracks the S&P Global 1200 Information Technology Index, covering tech leaders across both developed and emerging markets.

Read more on IXN →

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH →